Integra LifeSciences Holdings Corporation Forecast, price target & analysts
Integra LifeSciences Holdings Corporation Target price 2025 - Analyst rating & recommendation
Integra LifeSciences Holdings Corporation Classifications & Recommendation:
Integra LifeSciences Holdings Corporation Price Target
| Target Price | $26.25 |
| Price | $20.06 |
| Potential |
30.86%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Integra LifeSciences Holdings Corporation 2026 .
The average Integra LifeSciences Holdings Corporation target price is $26.25.
This is
30.86%
register free of charge
$35.00
74.48%
register free of charge
$20.00
0.30%
register free of charge
|
|
| A rating was issued by 13 analysts: 3 Analysts recommend Integra LifeSciences Holdings Corporation to buy, 6 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Integra LifeSciences Holdings Corporation stock has an average upside potential 2026 of
30.86%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.61 | 1.68 |
| 4.47% | 4.28% | |
| EBITDA Margin | 20.07% | 19.79% |
| 10.09% | 1.41% | |
| Net Margin | -0.43% | 4.29% |
| 110.26% | 1,094.80% |
11 Analysts have issued a sales forecast Integra LifeSciences Holdings Corporation 2025 . The average Integra LifeSciences Holdings Corporation sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Integra LifeSciences Holdings Corporation EBITDA forecast 2025. The average Integra LifeSciences Holdings Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Integra LifeSciences Holdings Corporation Analysts have issued a net profit forecast 2025. The average Integra LifeSciences Holdings Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.09 | 0.93 |
| 110.71% | 1,133.33% | |
| P/E | 21.49 | |
| EV/Sales | 1.94 |
3 Analysts have issued a Integra LifeSciences Holdings Corporation forecast for earnings per share. The average Integra LifeSciences Holdings Corporation EPS is
This results in the following potential growth metrics and future valuations:
Integra LifeSciences Holdings Corporation...
Current Integra LifeSciences Holdings Corporation Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Nov 05 2024 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Oct 14 2024 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Oct 07 2024 |
| BTIG |
Locked
➜
Locked
|
Locked | Oct 07 2024 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 01 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Argus Research:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Feb 26 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Nov 05 2024 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Oct 14 2024 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Oct 07 2024 |
|
Locked
BTIG:
Locked
➜
Locked
|
Oct 07 2024 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 01 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
